ACC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ACC Antibodies for investigating Acetyl-CoA Carboxylase (ACC) in various biological processes. Monoclonal ACC Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Acetyl-CoA Carboxylase is a key enzyme in fatty acid metabolism, playing a crucial role in the regulation of lipid synthesis and energy homeostasis. By converting Acetyl-CoA to malonyl-CoA, ACC influences both fatty acid oxidation and synthesis, making it an important target for studies related to metabolic disorders, obesity, and cardiovascular diseases. Understanding the function and regulation of ACC is vital for developing therapeutic strategies aimed at these conditions. ACC research has revealed significant insights into metabolic pathways and their regulation in various cell types. Ongoing studies continue to uncover new roles for ACC in cellular processes and disease mechanisms. Recent findings highlight ACC's involvement in cancer metabolism and potential therapeutic applications. Santa Cruz Biotechnology monoclonal ACC Antibodies enable researchers to advance scientific understanding of metabolic diseases and potential therapeutic interventions.